A new diabetes diagnosis tends to bring a moment of doubt about the first pill handed over, and the medical world has long answered that doubt with metformin: an old, affordable, well-studied drug that has earned its place at the starting line. Doctors quoted in The Indian Express explain why that choice persists and what other roads exist, from newer injectables and kidney-acting tablets to older drug families and a set of plant-derived and supplement options still awaiting fuller proof. Their steady message is that the path is walked with a physician rather than away from one, and that diet,
Afraid of Metformin After a Type 2 Diabetes Diagnosis? Experts Outline Alternatives and Their Trade-offs
Lifestyle changes complement medication rather than replace it
Mark
Why is metformin the default for newly diagnosed people?
Mimi
The doctors cite its long safety record, its low cost, and that it works at lowering blood sugar. Any stomach upset at the start often settles.
Mark
So what do people who refuse it have to choose from?
Mimi
GLP-1 injectables like Ozempic and Victoza, SGLT-2 pills like Jardiance and Farxiga, DPP-4 inhibitors, sulfonylureas and pioglitazone. Each has a different profile.
Luke
Worth noting these are described as options to discuss, not as equivalent swaps. The article doesn't compare how well they lower sugar against metformin.
Mark
What are the downsides of the older drugs?
Mimi
Sulfonylureas may cause weight gain and hypoglycemia. Pioglitazone can cause fluid retention and weight gain.
Mark
And the supplements, like berberine and cinnamon?
Mimi
Dr Singla says they've shown potential for insulin sensitivity, though long-term safety and efficacy need more research.
Luke
That's the weakest ground in the piece. Showing potential is not proof, and no dosages or trial results are given. The article also doesn't address cost or availability of the newer drugs.
Mark
What's the takeaway for someone hesitant?
Mimi
Don't stop or substitute on your own. Talk to the doctor, and treat diet and exercise as the foundation alongside medication.
Der Puls
- A fresh diagnosis of type 2 diabetes lands, and with it a prescription for metformin that many patients immediately want to question.
- Newer drug families such as GLP-1 agonists and SGLT-2 inhibitors offer weight and heart benefits, but each arrives with its own side effects to weigh.
- Older sulfonylureas and pioglitazone bring hypoglycemia, weight gain and fluid retention, sharpening the trade-offs patients must face.
- Supplements like berberine and cinnamon are being explored, yet their long-term safety remains unproven and experts urge caution.
- The clear resolution being pursued is a conversation with a doctor before any switch, with lifestyle changes steadying the course.
A new diabetes diagnosis tends to bring a moment of doubt about the first pill handed over, and the medical world has long answered that doubt with metformin: an old, affordable, well-studied drug that has earned its place at the starting line. Doctors quoted in The Indian Express explain why that choice persists and what other roads exist, from newer injectables and kidney-acting tablets to older drug families and a set of plant-derived and supplement options still awaiting fuller proof. Their steady message is that the path is walked with a physician rather than away from one, and that diet, movement and a healthy weight carry the work alongside whatever medicine is chosen.
A new diagnosis of type 2 diabetes often comes with a prescription for metformin, and for many people the first instinct is to wonder whether there is something better. The Indian Express took that question to doctors, who explained that metformin usually starts treatment for good reasons: a long safety record, a low price, and dependable blood-sugar control. Some people feel an upset stomach at first, though the experts note it often eases.
For those who want other options, Dr Narander Singla of CK Birla Hospital in Delhi described several classes to raise with a physician. GLP-1 receptor agonists such as Ozempic and Victoza are injectables that help control blood sugar while promoting weight loss and offering heart benefits. SGLT-2 inhibitors like Jardiance and Farxiga work through the kidneys, also aiding weight loss and lowering heart failure risk. DPP-4 inhibitors such as Januvia and Tradjenta boost incretin hormones that stimulate insulin.
Older drugs carry sharper trade-offs. Sulfonylureas can cause weight gain and low blood sugar, while pioglitazone can lead to fluid retention and weight gain. On the natural side, berberine, cinnamon, curcumin, myo-inositol, D-chiro inositol and NAC show promise, but experts say their long-term safety and effectiveness still need study.
Throughout, the advice is consistent: diet built on whole foods, regular exercise and a healthy weight support any treatment and never replace it. Above all, patients should not stop or swap medicines on their own. As Dr Ullal cautioned, expert guidance is how diabetes is managed well, and anyone uneasy about metformin should bring that concern to the clinic.
A new diagnosis of type 2 diabetes often arrives with a prescription for metformin, and for many people the first reaction is to question it. The Indian Express put that hesitation to doctors, who laid out why metformin is usually where treatment starts and what the other choices look like.
The case for metformin, as the experts describe it, rests on three things: a long safety record, a low price, and reliable blood-sugar lowering. Some people do get an upset stomach when they begin taking it, but the report notes that this side effect often fades.
For those who still don't want it, Dr Narander Singla, lead consultant in internal medicine at CK Birla Hospital in Delhi, listed several drug classes to raise with a doctor. The first is the GLP-1 receptor agonists, such as Ozempic (semaglutide) and Victoza (liraglutide). These are injectables that mimic a natural hormone to control blood sugar, and they also promote weight loss and offer cardiovascular benefits.
The second is the SGLT-2 inhibitors, such as Jardiance (empagliflozin) and Farxiga (dapagliflozin). These are oral drugs that help the kidneys clear glucose through urine. Dr Singla said they also support weight loss and lower the risk of heart failure.
Third are the DPP-4 inhibitors, including Januvia (sitagliptin) and Tradjenta (linagliptin). They raise levels of incretin hormones, which stimulate insulin production and reduce glucagon.
The older classes carry clearer trade-offs. Sulfonylureas such as glipizide and glyburide stimulate the pancreas to make insulin but may cause weight gain and hypoglycemia. Thiazolidinediones such as Actos (pioglitazone) improve insulin sensitivity but can lead to fluid retention and weight gain.
On the natural side, Dr Singla named berberine, cinnamon, curcumin, myo-inositol, D-chiro inositol and N-acetyl-cysteine (NAC). He said these have shown potential for improving insulin sensitivity and lowering blood sugar, but that more research is needed on their long-term safety and effectiveness.
Lifestyle changes underpin all of it. The experts point to a diet built on whole, unprocessed foods, regular physical activity and a healthy weight as significant supports for blood-sugar control. They describe these as complementing medication rather than replacing it.
The warning that runs through the piece is not to stop or swap medicine without a doctor's advice. Dr Ullal cautioned against trying medications on your own without knowing how they will affect the body, and said that following an expert's guidance is how diabetes gets managed. Anyone wary of metformin is best placed to take that wariness to the clinic and ask about the alternatives there.
Bemerkenswerte Zitate
Natural options such as berberine and cinnamon have shown potential, though more research is needed on long-term safety and efficacy.— Dr Narander Singla, CK Birla Hospital, Delhi
Don't try any medication on your own without knowing how it will affect the body; follow the expert's guidelines.— Dr Ullal
Möchten Sie die ganze Geschichte?
Das Original lesen bei The Indian Express ↗
Health & Medicine